SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-136675
Filing Date
2018-04-27
Accepted
2018-04-27 07:48:04
Documents
4
Period of Report
2018-06-20
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d279709ddef14a.htm DEF 14A 288352
2 GRAPHIC g279709g02n60.jpg GRAPHIC 40361
3 GRAPHIC g279709pc1.jpg GRAPHIC 203283
4 GRAPHIC g279709pc2.jpg GRAPHIC 119439
  Complete submission text file 0001193125-18-136675.txt   784856
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37783 | Film No.: 18781006
SIC: 2834 Pharmaceutical Preparations